Because of this, PTHrP might be used in obesity treatment for its ability to reprogram adipogenesis and adipose tissue expansion, favoring lipolysis, WAT browning and the improvement of the insulin sensitivity. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.